MAPT and Alzheimer disease: The core cerebrospinal fluid (CSF) biomarkers: total tau (T-tau), phosphorylated tau (P-tau) and the 42-amino acid form of Aβ (Aβ1–42) are the most frequently used as AD-related biomarkers [9,10].